The 5′-nucleotidases as regulators of nucleotide and drug metabolism

Pharmacology and Therapeutics

Volumn 107, Issue 1, 2005, Pages 1-30

  Hunsucker, Sally Anne ^a   Mitchell, Beverly S ^a,b   Spychala, Jozef ^a,b  

^a UNIVERSITY OF NORTH CAROLINA   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

Author keywords

Nucleoside analogues; Nucleoside metabolism; Nucleotidase

Indexed keywords

5' NUCLEOTIDASE; 5' NUCLEOTIDASE IA; 5' NUCLEOTIDASE IB; 5' NUCLEOTIDASE II; 5' NUCLEOTIDASE III; 5'(3') DEOXYRIBONUCLEOTIDASE; ANTHRACYCLINE; ANTINEOPLASTIC AGENT; ANTIVIRUS AGENT; BRYOSTATIN 1; CLADRIBINE; CYTARABINE; DEOXYRIBONUCLEOSIDE TRIPHOSPHATE; DOXORUBICIN; ECTO 5' NUCLEOTIDASE; FLUDARABINE; HYDROXYUREA; IDARUBICIN; NUCLEOSIDE DERIVATIVE; UNCLASSIFIED DRUG; VINBLASTINE; VINCRISTINE; ZIDOVUDINE; DRUG; NUCLEOTIDASE; NUCLEOTIDE;

ACUTE GRANULOCYTIC LEUKEMIA; DRUG METABOLISM; ENZYME KINETICS; ENZYME REGULATION; GENE STRUCTURE; HUMAN; LYMPHATIC LEUKEMIA; MULTIDRUG RESISTANCE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN STRUCTURE; REVIEW; GENETICS; KINETICS; METABOLISM; PHYSIOLOGY;

5'-NUCLEOTIDASE; HUMANS; KINETICS; NUCLEOTIDASES; NUCLEOTIDES; PHARMACEUTICAL PREPARATIONS;

EID: 20444368420     PISSN: 01637258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.pharmthera.2005.01.003     Document Type: Review

References (252)

1. I. Ahmad, A.M. Al-Katib, F.W. Beck, and R.M. Mohammad Sequential treatment of a resistant chronic lymphocytic leukemia patient with bryostatin 1 followed by 2-chlorodeoxyadenosine: case report Clin Cancer Res 6 2000 1328 1332
2. L. Airas, J. Hellman, M. Salmi, P. Bono, T. Puurunen, and D.J. Smith CD73 is involved in lymphocyte binding to the endothelium: characterization of lymphocyte-vascular adhesion protein 2 identifies it as CD73 J Exp Med 182 1995 1603 1608
3. L. Airas, J. Niemela, M. Salmi, T. Puurunen, D.J. Smith, and S. Jalkanen Differential regulation and function of CD73, a glycosyl-phosphatidylinositol- linked 70-kD adhesion molecule, on lymphocytes and endothelial cells J Cell Biol 136 1997 421 431
4. L. Airas, J. Niemela, and S. Jalkanen CD73 engagement promotes lymphocyte binding to endothelial cells via a lymphocyte function-associated antigen-1-dependent mechanism J Immunol 165 2000 5411 5417
5. S. Allegrini, R. Pesi, M.G. Tozzi, C.J. Fiol, R.B. Johnson, and S. Eriksson Bovine cytosolic IMP/GMP-specific 5′-nucleotidase: cloning and expression of active enzyme in Escherichia coli Biochem J 328 1997 483 487
6. S. Allegrini, A. Scaloni, L. Ferrara, R. Pesi, P. Pinna, and F. Sgarrella Bovine cytosolic 5′-nucleotidase acts through the formation of an aspartate 52-phosphoenzyme intermediate J Biol Chem 276 2001 33526 33532
7. A. Amici, and G. Magni Human erythrocyte pyrimidine 5′- nucleotidase, PN-1 Arch Biochem Biophys 397 2002 184 190
8. A. Amici, M. Emanuelli, G. Magni, N. Raffaelli, and S. Ruggieri Pyrimidine nucleotidases from human erythrocyte possess phosphotransferase activities specific for pyrimidine nucleotides FEBS Lett 419 1997 263 267
9. A. Amici, M. Emanuelli, N. Raffaelli, S. Ruggieri, F. Saccucci, and G. Magni Human erythrocyte pyrimidine 5-nucleotidase, PN-I, is identical to p36, a protein associated to lupus inclusion formation in response to alpha-interferon Blood 96 2000 1596 1598
10. A. Amici, M. Emanuelli, S. Ruggieri, N. Raffaelli, and G. Magni Kinetic evidence for covalent phosphoryl-enzyme intermediate in phosphotransferase activity of human red cell pyrimidine nucleotidases Methods Enzymol 354 2002 149 159
11. M.A. Armstrong, S. Shah, S.A. Hawkins, A.L. Bell, and D.S. Roberts Reduction of monocyte 5′-nucleotidase activity by gamma-interferon in multiple sclerosis and autoimmune diseases Ann Neurol 24 1988 12 16
12. E.S. Arner, and S. Eriksson Mammalian deoxyribonucleoside kinases Pharmacol Ther 67 1995 155 186
13. E. Arpaia, P. Benveniste, A. Di Cristofano, Y. Gu, I. Dalal, and S. Kelly Mitochondrial basis for immune deficiency. Evidence from purine nucleoside phosphorylase-deficient mice J Exp Med 191 2000 2197 2208
14. H. Asanuma, T. Minamino, S. Sanada, S. Takashima, H. Ogita, and A. Ogai Beta-adrenoceptor blocker carvedilol provides cardioprotection via an adenosine-dependent mechanism in ischemic canine hearts Circulation 109 2004 2773 2779
15. H. Asanuma, S. Sanada, A. Ogai, T. Minamino, S. Takashima, and M. Asakura Methotrexate and MX-68, a new derivative of methotrexate, limit infarct size via adenosine-dependent mechanisms in canine hearts J Cardiovasc Pharmacol 43 2004 574 579
16. D.E. Atkinson Adaptations of enzymes for regulation of catalytic function Biochem Soc Symp 41 1976 205 223
17. C. Baiocchi, R. Pesi, M. Camici, R. Itoh, and M.G. Tozzi Mechanism of reaction catalyzed by cytosolic 5′-nucleotidase/phosphotransferase: formation of a phosphorylated intermediate Biochem J 317 1996 797 801
18. M.I. Bak, and J.S. Ingwall Acidosis during ischemia promotes adenosine triphosphate resynthesis in postischemic rat heart. In vivo regulation of 5′-nucleotidase J Clin Invest 93 1994 40 49
19. M.I. Bak, and J.S. Ingwall Regulation of cardiac AMP-specific 5′-nucleotidase during ischemia mediates ATP resynthesis on reflow Am J Physiol 274 1998 C992 C1001
20. G. Balta, F. Gumruk, N. Akarsu, A. Gurgey, and C. Altay Molecular characterization of Turkish patients with pyrimidine 5′ nucleotidase-I deficiency Blood 102 2003 1900 1903
21. J. Balzarini, and E. De Clercq Nucleoside and nucleotide reverse transcriptase inhibitors E. De Clercq Antiretroviral Therapy 2001 ASM Press Washington, DC 31 62
22. J. Balzarini, C.K. Lee, P. Herdewijn, and E. Declercq Mechanism of the potentiating effect of ribavirin on the activity of 2′,3′- dideoxyinosine against human immunodeficiency virus J Biol Chem 266 1991 21509 21514
23. S. Banditelli, C. Baiocchi, R. Pesi, S. Allegrini, M. Turriani, and P.L. Ipata The phosphotransferase activity of cytosolic 5′-nucleotidase; a purine analog phosphorylating enzyme Int J Biochem Cell Biol 28 1996 711 720
24. V. Bardot, A.M. Dutrillaux, J.Y. Delattre, F. Vega, M. Poisson, and B. Dutrillaux Purine and pyrimidine metabolism in human gliomas: relation to chromosomal aberrations Br J Cancer 70 1994 212 218
25. C. Barsotti, R. Pesi, F. Felice, and P.L. Ipata The purine nucleoside cycle in cell-free extracts of rat brain: evidence for the occurrence of an inosine and a guanosine cycle with distinct metabolic roles Cell Mol Life Sci 60 2003 786 793
26. P.D. Bell, J.Y. Lapointe, R. Sabirov, S. Hayashi, J. Peti-Peterdi, and K. Manabe Macula densa cell signaling involves ATP release through a maxi anion channel Proc Natl Acad Sci U S A 100 2003 4322 4327
27. R.M. Berne, R.M. Knabb, S.W. Ely, and R. Rubio Adenosine in the local regulation of blood flow: a brief overview Fed Proc 42 1983 3136 3142
28. R.K. Bestwick, G.L. Moffett, and C.K. Mathews Selective expansion of mitochondrial nucleoside triphosphate pools in antimetabolite-treated HeLa cells J Biol Chem 257 1982 9300 9304
29. V. Bianchi, E. Pontis, and P. Reichard Interrelations between substrate cycles and de novo synthesis of pyrimidine deoxyribonucleoside triphosphates in 3T6 cells Proc Natl Acad Sci U S A 83 1986 986 990
30. V. Bianchi, P. Ferraro, S. Borella, P. Bonvini, and P. Reichard Effects of mutational loss of nucleoside kinases on deoxyadenosine 5′-phosphate/ deoxyadenosine substrate cycle in cultured CEM and V79 cells J Biol Chem 269 1994 16677 16683
31. P. Bianchi, E. Fermo, F. Alfinito, C. Vercellati, M. Baserga, and F. Ferraro Molecular characterization of six unrelated Italian patients affected by pyrimidine 5′-nucleotidase deficiency Br J Haematol 122 2003 847 851
32. M.R. Blackburn, S.K. Datta, and R.E. Kellems Adenosine deaminase-deficient mice generated using a two-stage genetic engineering strategy exhibit a combined immunodeficiency J Biol Chem 273 1998 5093 5100
33. D. Boison, L. Scheurer, V. Zumsteg, T. Rulicke, P. Litynski, and B. Fowler Neonatal hepatic steatosis by disruption of the adenosine kinase gene Proc Natl Acad Sci U S A 99 2002 6985 6990
34. L.L. Bondoc Jr., G. Ahluwalia, D.A. Cooney, N.R. Hartman, D.G. Johns, and A. Fridland Metabolic pathways for the activation of the antiviral agent 2′,3′-dideoxyguanosine in human lymphoid cells Mol Pharmacol 42 1992 525 530
35. J.M. Boyle, Y. Hey, K.H. Grzeschik, L. Thompson, E. Munro, and M. Fox Regional localization of human ecto-5′-nucleotidase to chromosome 6q14-q21 Hum Genet 83 1989 179 180
36. W.A. Brady, M.S. Kokoris, M. Fitzgibbon, and M.E. Black Cloning, characterization, and modeling of mouse and human guanylate kinases J Biol Chem 271 1996 16734 16740
37. N. Braun, C. Lenz, F. Gillardon, M. Zimmermann, and H. Zimmermann Focal cerebral ischemia enhances glial expression of ecto-5′-nucleotidase Brain Res 766 1997 213 226
38. E.G. Bridges, Z. Jiang, and Y.C. Cheng Characterization of a dCTP transport activity reconstituted from human mitochondria J Biol Chem 274 1999 4620 4625
39. R.M. Burger, and J.M. Lowenstein 5′-Nucleotidase from smooth muscle of small intestine and from brain. Inhibition of nucleotides Biochemistry 14 1975 2362 2366
40. M. Camici, C. Fini, and P.L. Ipata Isolation and kinetic properties of 5′-nucleotidase from guinea-pig skeletal muscle Biochim Biophys Acta 840 1985 6 12
41. O. Canbolat, I. Durak, R. Cetin, M. Kavutcu, S. Demirci, and S. Ozturk Activities of adenosine deaminase, 5′-nucleotidase, guanase, and cytidine deaminase enzymes in cancerous and non-cancerous human breast tissues Breast Cancer Res Treat 37 1996 189 193
42. D.A. Carson, C.J. Carrera, D.B. Wasson, and T. Iizasa Deoxyadenosine-resistant human T-lymphoblasts with elevated 5′- nucleotidase activity Biochim Biophys Acta 1091 1991 22 28
43. C.E. Cass, J.D. Young, S.A. Baldwin, M.A. Cabrita, K.A. Graham, and M. Griffiths Nucleoside transporters of mammalian cells Pharm Biotechnol 12 1999 313 352
44. H. Castrop, Y. Huang, S. Hashimoto, D. Mizel, P. Hansen, and F. Theilig Impairment of tubuloglomerular feedback regulation of GFR in ecto-5′-nucleotidase/CD73-deficient mice J Clin Invest 114 2004 634 642
45. A.H. Chalmers, C. Hare, G. Woolley, and I.H. Frazer Lymphocyte ectoenzyme activity compared in healthy persons and patients seropositive to or at high risk of HIV infection Immunol Cell Biol 68 Pt 2 1990 81 85
46. C.H. Chen, and Y.C. Cheng The role of cytoplasmic deoxycytidine kinase in the mitochondrial effects of the anti-human immunodeficiency virus compound, 2′,3′-dideoxycytidine J Biol Chem 267 1992 2856 2859
47. L.D. Christensen, V. Andersen, P. Nygaard, and K. Bendtzen Effects of immunomodulators on ecto-5′-nucleotidase activity on blood mononuclear cells invitro Scand J Immunol 35 1992 407 413
48. A. Cohen, L.J. Gudas, A.J. Ammann, G.E. Staal, and D.W. Martin Jr. Deoxyguanosine triphosphate as a possible toxic metabolite in the immunodeficiency associated with purine nucleoside phosphorylase deficiency J Clin Invest 61 1978 1405 1409
49. A. Cohen, R. Hirschhorn, S.D. Horowitz, A. Rubinstein, S.H. Polmar, and R. Hong Deoxyadenosine triphosphate as a potentially toxic metabolite in adenosine deaminase deficiency Proc Natl Acad Sci U S A 75 1978 472 476
50. J.F. Collet, V. Stroobant, M. Pirard, G. Delpierre, and E. Van Schaftingen A new class of phosphotransferases phosphorylated on an aspartate residue in an amino-terminal DXDX(T/V) motif J Biol Chem 273 1998 14107 14112
51. A.R. Collinson, K.J. Peuhkurinen, and J.M. Lowenstein Regulation and function of 5′-nucleotidases E. Gerlach Topics and perspectives in Adenosine research 1987 Springer-Verlag Berlin 133 144
52. L.H. Cragg, M. Andreeff, E. Feldman, J. Roberts, A. Murgo, and M. Winning Phase I trial and correlative laboratory studies of bryostatin 1 (NSC 339555) and high-dose 1-B-d-arabinofuranosylcytosine in patients with refractory acute leukemia Clin Cancer Res 8 2002 2123 2133
53. A. Darvish, and P.J. Metting Purification and regulation of an AMP-specific cytosolic 5′-nucleotidase from dog heart Am J Physiol 264 1993 H1528 H1534
54. A. Darvish, J.J. Postlewaite, and P.J. Metting Immunogold localization of adenosine 5′-monophosphate specific cytosolic 5′-nucleotidase in dog heart Hypertension 21 1993 906 910
55. H. de Koning, and G. Diallinas Nucleobase transporters (review) Mol Membr Biol 17 2000 75 94
56. U.K.M. Decking, G. Schlieper, K. Kroll, and J. Schrader Hypoxia-induced inhibition of adenosine kinase potentiates cardiac adenosine release Circ Res 81 1997 154 164
57. A. Deussen, H.G.E. Lloyd, and J. Schrader Contribution of S-adenosylhomocysteine to cardiac adenosine formation J Mol Cell Cardiol 21 1989 773 782
58. J. Dieckhoff, H. Knebel, M. Heidemann, and H.G. Mannherz An improved procedure for purifying 5′-nucleotidase from various sources. Evidence for tissue and species specific differences in their molecular mass and affinity for F-actin Eur J Biochem 151 1985 377 383
59. V. Dolce, G. Fiermonte, M.J. Runswick, F. Palmieri, and J.E. Walker The human mitochondrial deoxynucleotide carrier and its role in the toxicity of nucleoside antivirals Proc Natl Acad Sci U S A 98 2001 2284 2288
60. A. Dowlati, H.M. Lazarus, P. Hartman, J.W. Jacobberger, C. Whitacre, and S.L. Gerson Phase I and correlative study of combination bryostatin 1 and vincristine in relapsed B-cell malignancies Clin Cancer Res 9 2003 5929 5935
61. S. Dragon, R. Hille, R. Gotz, and R. Baumann Adenosine 3′:5′-cyclic monophosphate (cAMP)-inducible pyrimidine 5′-nucleotidase and pyrimidine nucleotide metabolism of chick embryonic erythrocytes Blood 91 1998 3052 3058
62. C. Dumontet, K. Fabianowska-Majewska, D. Mantincic, E. Callet Bauchu, I. Tigaud, and V. Gandhi Common resistance mechanisms to deoxynucleoside analogues in variants of the human erythroleukaemic line K562 Br J Haematol 106 1999 78 85
63. I. Durak, R. Cetin, O. Canbolat, D. Cetin, Z. Yurtarslani, and A. Unal Adenosine deaminase, 5′-nucleotidase, guanase and cytidine deaminase activities in gastric tissues from patients with gastric cancer Cancer Lett 84 1994 199 202
64. M.H. el Kouni Potential chemotherapeutic targets in the purine metabolism of parasites Pharmacol Ther 99 2003 283 309
65. H.K. Eltzschig, J.C. Ibla, G.T. Furuta, M.O. Leonard, K.A. Jacobson, and K. Enjyoji Coordinated adenine nucleotide phosphohydrolysis and nucleoside signaling in posthypoxic endothelium: role of ectonucleotidases and adenosine A2B receptors J Exp Med 198 2003 783 796
66. H.K. Eltzschig, L.F. Thompson, J. Karhausen, R.J. Cotta, J.C. Ibla, and S.C. Robson Endogenous adenosine produced during hypoxia attenuates neutrophil accumulation: coordination by extracellular nucleotide metabolism Blood 104 2004 3986 3992
67. I. Feoktistov, S. Ryzhov, H. Zhong, A.E. Goldstein, A. Matafonov, and D. Zeng Hypoxia modulates adenosine receptors in human endothelial and smooth muscle cells toward an A2B angiogenic phenotype Hypertension 44 2004 649 654
68. H. Fleit, M. Conklyn, R.D. Stebbins, and R. Silber Function of 5′-nucleotidase in the uptake of adenosine from AMP by human lymphocytes J Biol Chem 250 1975 8889 8892
69. K. Flocke, and H.G. Mannherz Isolation and characterization of 5′-nucleotidase of a human pancreatic tumor cell line Biochim Biophys Acta 1076 1991 273 281
70. A. Fridland, M.C. Connelly, and T.J. Robbins Tiazofurin metabolism in human lymphoblastoid cells: evidence for phosphorylation by adenosine kinase and 5′-nucleotidase Cancer Res 46 1986 532 537
71. P. Fritzson Regulation of nucleotidase activities in animal tissues Adv Enzyme Regul 16 1977 43 61
72. P. Fritzson, and I. Smith A new nucleotidase of rat liver with activity toward 3′- and 5′-nucleotides Biochim Biophys Acta 235 1971 128 141
73. Y. Fukunaga, S.S. Evans, M. Yamamoto, Y. Ueda, K. Tamura, and T. Takakuwa Increased density of ecto 5′ nucleotidase antigen on leukemic T cells from patients with cutaneous T-cell lymphoma and adult T-cell leukemia/lymphoma Blood 74 1989 2486 2492
74. L. Gallinaro, K. Crovatto, C. Rampazzo, G. Pontarin, P. Ferraro, and E. Milanesi Human mitochondrial 5′-deoxyribonucleotidase. Overproduction in cultured cells and functional aspects J Biol Chem 277 2002 35080 35087
75. C.M. Galmarini, K. Graham, X. Thomas, F. Calvo, P. Rousselot, and A. El Jafaari Expression of high Km 5′-nucleotidase in leukemic blasts is an independent prognostic factor in adults with acute myeloid leukemia Blood 98 2001 1922 1926
76. C.M. Galmarini, J.R. Mackey, and C. Dumontet Nucleoside analogues: mechanisms of drug resistance and reversal strategies Leukemia 15 2001 875 890
77. C.M. Galmarini, X. Thomas, F. Calvo, P. Rousselot, A.E. Jafaari, and E. Cros Potential mechanisms of resistance to cytarabine in AML patients Leukemia Res 26 2002 621 629
78. C.M. Galmarini, X. Thomas, F. Calvo, P. Rousselot, M. Rabilloud, and A. El Jaffari In vivo mechanisms of resistance to cytarabine in acute myeloid leukaemia Br J Haematol 117 2002 860 868
79. C.M. Galmarini, L. Jordheim, and C. Dumontet Role of IMP-selective 5′-nucleotidase (cN-II) in hematological malignancies Leuk Lymphoma 44 2003 1105 1111
80. C.M. Galmarini, X. Thomas, K. Graham, A. El Jafaari, E. Cros, and L. Jordheim Deoxycytidine kinase and cN-II nucleotidase expression in blast cells predict survival in acute myeloid leukaemia patients treated with cytarabine Br J Haematol 122 2003 53 60
81. C.M. Galmarini, E. Cros, K. Graham, X. Thomas, J.R. Mackey, and C. Dumontet 5-(3)-Nucleotidase mRNA levels in blast cells are a prognostic factor in acute myeloid leukemia patients treated with cytarabine Haematologica 89 2004 617 619
82. V. Gandhi, and W. Plunkett Cellular and clinical pharmacology of fludarabine Clin Pharmacokinet 41 2002 93 103
83. E.P. Garvey, and K.L. Prus A specific inhibitor of heart cytosolic 5′-nucleotidase I attenuates hydrolysis of adenosine 5′- monophosphate in primary rat myocytes Arch Biochem Biophys 364 1999 235 240
84. E.P. Garvey, G.T. Lowen, and M.R. Almond Nucleotide and nucleoside analogues as inhibitors of cytosolic 5′-nucleotidase I from heart Biochemistry 37 1998 9043 9051
85. C. Gazziola, M. Moras, P. Ferraro, L. Gallinaro, R. Verin, and C. Rampazzo Induction of human high K(M) 5′-nucleotidase in cultured 293 cells Exp Cell Res 253 1999 474 482
86. C. Gazziola, P. Ferraro, M. Moras, P. Reichard, and V. Bianchi Cytosolic high K(m) 5′-nucleotidase and 5′(3′)-deoxyribonucleotidase in substrate cycles involved in nucleotide metabolism J Biol Chem 276 2001 6185 6190
87. E.R. Giblett, J.E. Anderson, F. Cohen, B. Pollara, and H.J. Meuwissen Adenosine-deaminase deficiency in two patients with severely impaired cellular immunity Lancet 2 1972 1067 1069
88. B.W. Gibson, and G.I. Drummond Properties of 5′-nucletidase from avian heart Biochemistry 11 1972 223 229
89. S. Grant Ara-C: cellular and molecular pharmacology Adv Cancer Res 72 1998 197 233
90. L.A. Gustafson, and K. Kroll Downregulation of 5′-nucleotidase in rabbit heart during coronary underperfusion Am J Physiol 274 1998 H529 H538
91. W. Gutensohn, and E. Thiel Prognostic implication of ecto-5′- nucleotidase activity in acute lymphoblastic leukemia Cancer 66 1990 1755 1758
92. W. Gutensohn, R. Resta, Y. Misumi, Y. Ikehara, and L.F. Thompson Ecto-5′-nucleotidase activity is not required for T cell activation through CD73 Cell Immunol 161 1995 213 217
93. K.R. Hansen, R. Resta, C.F. Webb, and L.F. Thompson Isolation and characterization of the promoter of the human 5′-nucleotidase (CD73)-encoding gene Gene 167 1995 307 312
94. R.H. Haynes, and B.A. Kunz The influence of thymine nucleotide depletion on genetic stability and change in eucaryotic cells Current 1986 55
95. J.P. Headrick, B. Hack, and K.J. Ashton Acute adenosinergic cardioprotection in ischemic-reperfused hearts Am J Physiol Heart Circ Physiol 285 2003 H1797 H1818
96. L. Hoglund, and P. Reichard Cytoplasmic 5′(3′)-nucleotidase from human placenta J Biol Chem 265 1990 6589 6595
97. D.A. Hopkinson, D.M. Swallow, A. Marinaki, and E.H. Harley Pyrimidine 5′-nucleotidase activity in normal and deficient human lymphoblastoid cells J Inherit Metab Dis 13 1990 701 706
98. S.A. Hunsucker, J. Spychala, and B.S. Mitchell Human cytosolic 5′-nucleotidase: I. characterization and role in nucleoside analog resistance J Biol Chem 276 2001 10498 10504
99. R. Itoh IMP-GMP 5′-nucleotidase Comp Biochem Physiol B 105 1993 13 19
100. R. Itoh, A. Mitsui, and K. Tsushima 5′-nucleotidase of chicken liver Biochim Biophys Acta 146 1967 151 159
101. R. Itoh, H. Echizen, M. Higuchi, J. Oka, and K. Yamada A comparative study on tissue distribution and metabolic adaptation of IMP-GMP 5′-nucleotidase Comp Biochem Physiol B 103 1992 153 159
102. W. Jager, A. Salamon, and T. Szekeres Metabolism of the novel IMP dehydrogenase inhibitor benzamide riboside Curr Med Chem 9 2002 781 786
103. T. Jamil, R.A. Fisher, and H. Harris Studies on the properties and tissue distribution of the isozymes of guanylate kinase in man Hum Hered 25 1975 402 413
104. R.B. Jennings, and C. Steenbergen Jr. Nucleotide metabolism and cellular damage in myocardial ischemia Annu Rev Physiol 47 1985 727 749
105. M.A. Johnson, and A. Fridland Phosphorylation of 2′,3′- dideoxyinosine by cytosolic 5′-nucleotidase of human lymphoid cells Mol Pharmacol 36 1989 291 295
106. A. Jordan, and P. Reichard Ribonucleotide reductases Annu Rev Biochem 67 1998 71 98
107. K. Kalsi, C. Lawson, M. Dominguez, P. Taylor, M.H. Yacoub, and R.T. Smolenski Regulation of ecto-5′-nucleotidase by TNF-alpha in human endothelial cells Mol Cell Biochem 232 2002 113 119
108. H. Kanno, T. Takizawa, S. Miwa, and H. Fujii Molecular basis of Japanese variants of pyrimidine 5′-nucleotidase deficiency Br J Haematol 126 2004 265 271
109. H. Kawasaki, C.J. Carrera, L.D. Piro, A. Saven, T.J. Kipps, and D.A. Carson Relationship of deoxycytidine kinase and cytoplasmic 5′- nucleotidase to the chemotherapeutic efficacy of 2-chlorodeoxyadenosine Blood 81 1993 597 601
110. P.M. Keller, S.A. McKee, and J.A. Fyfe Cytoplasmic 5′-nucleotidase catalyzes acyclovir phosphorylation J Biol Chem 260 1985 8664 8667
111. A.B. Kier, M.T. Parker, and F. Schroeder Local and metastatic tumor growth and membrane properties of LM fibroblasts in athymic (nude) mice Biochim Biophys Acta 938 1988 434 446
112. Y. Kim, H. Lee, C.R. Lee, D.U. Park, J.S. Yang, and I.J. Park Evaluation of lead exposure in workers at secondary lead smelters in South Korea: with focus on activity of erythrocyte pyrimidine 5′-nucleotidase (P5N) Sci Total Environ 286 2002 181 189
113. L.L. Kisselev, J. Justesen, A.D. Wolfson, and L.Y. Frolova Diadenosine oligophosphates (Ap(n)A), a novel class of signalling molecules? FEBS Lett 427 1998 157 163
114. M. Kitakaze, T. Minamino, K. Node, K. Komamura, and M. Hori Activation of ecto-5′-nucleotidase and cardioprotection by ischemic preconditioning Basic Res Cardiol 91 1996 23 26
115. M. Kitakaze, T. Minamino, K. Node, K. Komamura, M. Inoue, and M. Hori Activation of ecto-5′-nucleotidase by protein kinase C attenuates irreversible cellular injury due to hypoxia and reoxygenation in rat cardiomyocytes J Mol Cell Cardiol 28 1996 1945 1955
116. M. Kitakaze, K. Node, T. Minamino, K. Komamura, H. Funaya, and Y. Shinozaki Role of activation of protein kinase C in the infarct size-limiting effect of ischemic preconditioning through activation of ecto-5′- nucleotidase Circulation 93 1996 781 791
117. M. Kitakaze, T. Minamino, H. Funaya, K. Node, Y. Shinozaki, and H. Mori Vesnarinone limits infarct size via adenosine-dependent mechanisms in the canine heart Circulation 95 1997 2108 2114
118. M. Kitakaze, T. Minamino, K. Node, S. Takashima, H. Funaya, and T. Kuzuya Adenosine and cardioprotection in the diseased heart Jpn Circ J 63 1999 231 243
119. T. Klabunde, N. Strater, R. Frohlich, H. Witzel, and B. Krebs Mechanism of Fe(III)-Zn(II) purple acid phosphatase based on crystal structures J Mol Biol 259 1996 737 748
120. T. Knofel, and N. Strater X-ray structure of the Escherichia coli periplasmic 5′-nucleotidase containing a dimetal catalytic site Nat Struct Biol 6 1999 448 453
121. T. Knofel, and N. Strater Mechanism of hydrolysis of phosphate esters by the dimetal center of 5′-nucleotidase based on crystal structures J Mol Biol 309 2001 239 254
122. P. Koszalka, B. Ozuyaman, Y. Huo, A. Zernecke, U. Flogel, and N. Braun Targeted disruption of cd73/ecto-5′-nucleotidase alters thromboregulation and augments vascular inflammatory response Circ Res 95 2004 814 821
123. A.S. Kraft, F. William, G.R. Pettit, and M.B. Lilly Varied differentiation responses of human leukemias to bryostatin 1 Cancer Res 49 1989 1287 1293
124. K.C. Kuijpers, J.J.M. Vandongen, P. Vanderburg, M.T. Roos, J. Vonk, and R. Deabreu A combined immunodeficiency with oligoclonal CD8+, Vbeta3-expressing, cytotoxic lymphocytes-T in the peripheral blood J Immunol 149 1992 3403 3410
125. B.A. Kunz, and S.E. Kohalmi Modulation of mutagenesis by deoxyribonucleotide levels Annu Rev Genet 25 1991 339 359
126. B.A. Kunz, S.E. Kohalmi, T.A. Kunkel, C.K. Mathews, E.M. McIntosh, and J.A. Reidy Deoxyribonucleoside triphosphate levels: a critical factor in the maintenance of genetic stability Mutat Res 318 1994 1 64
127. M. Le Hir, R. Gandhi, and U.C. Dubach Purification and properties of a 5′-nucleotidase from rat renal membranes Enzyme 41 1989 87 93
128. S. Ledoux, C. Leroy, G. Siegfried, D. Prie, P. Moullier, and G. Friedlander Overexpression of ecto-5′-nucleotidase promotes P-glycoprotein expression in renal epithelial cells Kidney Int 52 1997 953 961
129. S. Ledoux, I. Runembert, K. Koumanov, J.B. Michel, G. Trugnan, and G. Friedlander Hypoxia enhances ecto-5′-nucleotidase activity and cell surface expression in endothelial cells: role of membrane lipids Circ Res 92 2003 848 855
130. A.H. Lee, E.A. Dublin, and L.G. Bobrow Angiogenesis and expression of thymidine phosphorylase by inflammatory and carcinoma cells in ductal carcinoma in situ of the breast J Pathol 187 1999 285 290
131. J.M. Leeds, M.B. Slabaugh, and C.K. Mathews DNA precursor pools and ribonucleotide reductase activity: distribution between the nucleus and cytoplasm of mammalian cells Mol Cell Biol 5 1985 3443 3450
132. P.F. Lennon, C.T. Taylor, G.L. Stahl, and S.P. Colgan Neutrophil-derived 5′-adenosine monophosphate promotes endothelial barrier J Exp Med 188 1998 1433 1443
133. A.N. Lestas, K.H. Nicolaides, C.H. Rodeck, and A.J. Bellingham Normal levels of ATP, total nucleotides and activities of three enzymes related to nucleotide metabolism in fetal erythrocytes Br J Haematol 63 1986 471 476
134. W.A. Lewis, and M.C. Dalakas Mitochondrial toxicity of antiviral drugs Nat Med 1 1995 417 422
135. J.Y. Liou, G.E. Dutschman, W. Lam, Z. Jiang, and Y.C. Cheng Characterization of human UMP/CMP kinase and its phosphorylation of D- and L-form deoxycytidine analogue monophosphates Cancer Res 62 2002 1624 1631
136. B. Lipstein, P. Boer, and O. Sperling Regulation of de novo purine synthesis in chick liver slices. Role of phosphoribosylpyrophosphate availability and of salvage purine nucleotide synthesis Biochim Biophys Acta 521 1978 45 54
137. K. Lotfi, E. Mansson, J. Chandra, Y. Wang, D. Xu, and E. Knaust Pharmacological basis for cladribine resistance in a human acute T lymphoblastic leukaemia cell line selected for resistance to etoposide Br J Haematol 113 2001 339 346
138. M.M. Lu, F. Chen, A. Gitler, J. Li, F. Jin, and X.K. Ma Cloning and expression analysis of murine lupin, a member of a novel gene family that is conserved through evolution and associated with Lupus inclusions Dev Genes Evol 210 2000 512 517
139. W.M. MacKenzie, D.W. Hoskin, and J. Bly Adenosine inhibits the adhesion of anti-CD3-activated killer lymphocytes to adenocarcinoma cells through an A3 receptor Cancer Res 54 1994 3521 3526
140. F. Maley, and G.F. Maley A tale of two enzymes, deoxycytidylate deaminase and thymidylate synthase Prog Nucleic Acid Res Mol Biol 39 1990 49 80
141. H. Mandel, R. Szargel, V. Labay, O. Elpeleg, A. Saada, and A. Shalata The deoxyguanosine kinase gene is mutated in individuals with depleted hepatocerebral mitochondrial DNA Nat Genet 29 2001 337 341
142. A.M. Marinaki, E. Escuredo, J.A. Duley, H.A. Simmonds, A. Amici, and V. Naponelli Genetic basis of hemolytic anemia caused by pyrimidine 5′ nucleotidase deficiency Blood 97 2001 3327 3332
143. A.F. Marques, N.A. Teixeira, C. Gambaretto, A. Sillero, and M.A. Sillero IMP-GMP 5′-nucleotidase from rat brain: activation by J Neurochem 71 1998 1241 1250
144. M. Massaia, L. Perrin, A. Bianchi, J. Ruedi, C. Attisano, and D. Altieri Human T cell activation. Synergy between CD73 (ecto-5′-nucleotidase) and signals delivered through CD3 and CD2 molecules J Immunol 145 1990 1664 1674
145. C. Mazzon, C. Rampazzo, M.C. Scaini, L. Gallinaro, A. Karlsson, and C. Meier Cytosolic and mitochondrial deoxyribonucleotidases: activity with substrate analogs, inhibitors and implications for therapy Biochem Pharmacol 66 2003 471 479
146. K. Meflah, J. Harb, Y. Duflos, and S. Bernard 5′-Nucleotidase from bovine caudate nucleus synaptic plasma membranes: specificity for substrates and cations; study of the carbohydrate moiety by glycosidases J Neurochem 42 1984 1107 1115
147. P. Meghji, K.M. Middleton, and A.C. Newby Absolute rates of adenosine formation during ischaemia in rat and pigeon hearts Biochem J 249 1988 695 703
148. A.A. Migchielsen, M.L. Breuer, M.A. van Roon, H. te Riele, C. Zurcher, and F. Ossendorp Adenosine-deaminase-deficient mice die perinatally and exhibit liver-cell degeneration, atelectasis and small intestinal cell death Nat Genet 10 1995 279 287
149. Y. Misumi, S. Ogata, S. Hirose, and Y. Ikehara Primary structure of rat liver 5′-nucleotidase deduced from the cDNA J Biol Chem 265 1990 2178 2183
150. Y. Misumi, S. Ogata, K. Ohkubo, S. Hirose, and Y. Ikehara Primary structure of human placental 5′-nucleotidase and identification of the glycolipid anchor in the mature form Eur J Biochem 191 1990 563 569
151. R.M. Mohammad, F.W. Beck, K. Katato, N. Hamdy, N. Wall, and A. Al-Katib Potentiation of 2-chlorodeoxyadenosine activity by bryostatin 1 in the resistant chronic lymphocytic leukemia cell line (WSU-CLL): association with increased ratios of dCK/5′-NT and Bax/Bcl-2 Biol Chem 379 1998 1253 1261
152. A.W. Murray The biological significance of purine salvage Annu Rev Biochem 40 1971 811 826
153. C.E. Murry, R.B. Jennings, and K.A. Reimer Preconditioning with ischemia: a delay of lethal cell injury in ischemic myocardium Circulation 74 1986 1124 1136
154. Y. Naito, and J.M. Lowenstein 5′-Nucleotidase from rat heart Biochemistry 20 1981 5188 5194
155. Y. Naito, and J.M. Lowenstein 5′-Nucleotidase from rat heart membranes. Inhibition by adenine nucleotides and related compounds Biochem J 226 1985 645 651
156. S. Narravula, P.F. Lennon, B.U. Mueller, and S.P. Colgan Regulation of endothelial CD73 by adenosine: paracrine pathway for enhanced endothelial barrier function J Immunol 165 2000 5262 5268
157. E. Nemoto, R. Kunii, H. Tada, T. Tsubahara, H. Ishihata, and H. Shimauchi Expression of CD73/ecto-5′-nucleotidase on human gingival fibroblasts and contribution to the inhibition of interleukin-1alpha-induced granulocyte-macrophage colony stimulating factor production J Periodontal Res 39 2004 10 19
158. A.C. Newby Adenosine and the concept of 'retaliatroy metabolites' Trends Biochem Sci 9 1984 42 44
159. A.C. Newby The pigeon heart 5′-nucleotidase responsible for ischemia-induced adenosine formation Biochem J 253 1988 123 130
160. I. Nishino, A. Spinazzola, and M. Hirano Thymidine phosphorylase gene mutations in MNGIE, a human mitochondrial disorder Science 283 1999 689 692
161. J. Oka, A. Matsumoto, Y. Hosokawa, and S. Inoue Molecular cloning of human cytosolic purine 5′-nucleotidase Biochem Biophys Res Commun 205 1994 917 922
162. T. Page, A. Yu, J. Fontanesi, and W.L. Nyhan Developmental disorder associated with increased cellular nucleotidase activity Proc Natl Acad Sci U S A 94 1997 11601 11606
163. E.D. Paglia, and W.N. Valentine Characteristics of pyrimidine-specific 5′-nucleotidase in human erythrocytes J Biol Chem 250 1975 7973 7979
164. D.E. Paglia, W.N. Valentine, and K. Fink Lead poisoning. Further observations on erythrocyte pyrimidine-nucleotidase deficiency and intracellular accumulation of pyrimidine nucleotides J Clin Invest 60 1977 1362 1366
165. D.E. Paglia, W.N. Valentine, and R.A. Brockway Identification of thymidine nucleotidase and deoxyribonucleotidase activities among normal isozymes of 5′-nucleotidase in human erythrocytes Proc Natl Acad Sci U S A 81 1984 588 592
166. C. Parr, and W.G. Jiang Quantitative analysis of lymphangiogenic markers in human colorectal cancer Int J Oncol 23 2003 533 539
167. J. Peart, G.P. Matherne, R.J. Cerniway, and J.P. Headrick Cardioprotection with adenosine metabolism inhibitors in ischemic-reperfused mouse heart Cardiovasc Res 52 2001 120 129
168. S. Peola, P. Borrione, L. Matera, F. Malavasi, A. Pileri, and M. Massaia Selective induction of CD73 expression in human lymphocytes by CD38 ligation: a novel pathway linking signal transducers with ecto-enzyme activities J Immunol 157 1996 4354 4362
169. R. Pesi, M. Turriani, S. Allegrini, C. Scolozzi, M. Camici, and P.L. Ipata The bifunctional cytosolic 5′-nucleotidase: regulation of the phosphotransferase and nucleotidase activities Arch Biochem Biophys 312 1994 75 80
170. R. Pesi, S. Allegrini, S. Golfarini, C. Baiocchi, E. Moretti, and M. Camici Identification of multiple forms of the cytosolic 5′-nucleotidase/ phosphotransferase in rat tissues Adv Exp Med Biol 431 1998 495 499
171. R. Pesi, C. Baiocchi, S. Allegrini, E. Moretti, F. Sgarrella, and M. Camici Identification, separation and characterisation of two forms of cytosolic 5′-nucleotidase/nucleoside phosphotransferase in calf thymus Biol Chem 379 1998 699 704
172. R. Pieters, D.R. Huismans, A.H. Loonen, G.J. Peters, K. Hahlen, and A.V. Vandenberg Relation of 5′-nucleotidase and phosphatase activities with immunophenotype, drug resistance and clinical prognosis in childhood leukemia Leuk Res 16 1992 873 880
173. R.B. Pilz, R.C. Willis, and G.R. Boss The influence of ribose 5-phosphate availability on purine synthesis of cultured human lymphoblasts and mitogen-stimulated lymphocytes J Biol Chem 259 1984 2927 2935
174. R.M. Pinto, J. Canales, S.M.A. Gunther, and A. Sillero Diadenosine tetraphosphate activates cytosol 5′-nucleotidase Biochem Biophys Res Commun 138 1986 261 267
175. G. Pontarin, L. Gallinaro, P. Ferraro, P. Reichard, and V. Bianchi Origins of mitochondrial thymidine triphosphate: dynamic relations to cytosolic pools Proc Natl Acad Sci U S A 100 2003 12159 12164
176. m 5′-nucleotidase effects of overexpression of the cloned cDNA in cultured human cells Eur J Biochem 261 1999 689 697
177. C. Rampazzo, L. Gallinaro, E. Milanesi, E. Frigimelica, P. Reichard, and V. Bianchi A deoxyribonucleotidase in mitochondria: involvement in regulation of dNTP pools and possible link to genetic disease Proc Natl Acad Sci U S A 97 2000 8239 8244
178. C. Rampazzo, M. Johansson, L. Gallinaro, P. Ferraro, U. Hellman, and A. Karlsson Mammalian 5′(3′)-deoxyribonucleotidase, cDNA cloning, and overexpression of the enzyme in Escherichia coli and mammalian cells J Biol Chem 275 2000 5409 5415
179. C. Rampazzo, M. Kost-Alimova, B. Ruzzenente, J.P. Dumanski, and V. Bianchi Mouse cytosolic and mitochondrial deoxyribonucleotidases: cDNA cloning of the mitochondrial enzyme, gene structures, chromosomal mapping and comparison with the human orthologs Gene 294 2002 109 117
180. C. Rampazzo, C. Mazzon, P. Reichard, and V. Bianchi 5′- Nucleotidases: specific assays for five different enzymes in cell extracts Biochem Biophys Res Commun 293 2002 258 263
181. C. Rampazzo, P. Ferraro, G. Pontarin, S. Fabris, P. Reichard, and V. Bianchi Mitochondrial deoxyribonucleotides, pool sizes, synthesis, and regulation J Biol Chem 279 2004 17019 17026
182. M. Razmara, S. Eriksson, and F. Albertioni 5′-nucleotidases levels measured in peripheral blood cells from patients with chronic and acute leukemia Abstracts, Joint 11th International and 9th European Symposium on Purines and Pyrimidines in Man, Egmond aan Zee June 9-13 2003 Abstract P82
183. D.C. Rees, J. Duley, H.A. Simmonds, B. Wonke, S.L. Thein, and J.B. Clegg Interaction of hemoglobin E and pyrimidine 5′ nucleotidase deficiency Blood 88 1996 2761 2767
184. D.C. Rees, J.A. Duley, and A.M. Marinaki Pyrimidine 5′ nucleotidase deficiency Br J Haematol 120 2003 375 383
185. R. Resta, S.W. Hooker, K.R. Hansen, A.B. Laurent, J.L. Park, and M.R. Blackburn Murine ecto-5′-nucleotidase (CD73)- cDNA cloning and tissue distribution Gene 133 1993 171 177
186. R. Resta, Y. Yamashita, and L.F. Thompson Ecto-enzyme and signaling functions of lymphocyte CD73 Immunol Rev 161 1998 95 109
187. S.A. Rich, M. Bose, P. Tempst, and U.H. Rudofsky Purification, microsequencing, and immunolocalization of p36, a new interferon-alpha-induced protein that is associated with human lupus inclusions J Biol Chem 271 1996 1118 1126
188. A. Rinaldo-Matthis, C. Rampazzo, P. Reichard, V. Bianchi, and P. Nordlund Crystal structure of a human mitochondrial deoxyribonucleotidase Nat Struct Biol 9 2002 779 787
189. A. Rinaldo-Matthis, C. Rampazzo, J. Balzarini, P. Reichard, V. Bianchi, and P. Nordlund Crystal structures of the mitochondrial deoxyribonucleotidase in complex with two specific inhibitors Mol Pharmacol 65 2004 860 867
190. M.J. Rosenberg, R. Agarwala, G. Bouffard, J. Davis, G. Fiermonte, and M.S. Hilliard Mutant deoxynucleotide carrier is associated with congenital microcephaly Nat Genet 32 2002 175 179
191. F. Rosi, A.B. Agostinho, F. Carlucci, L. Zanoni, B. Porcelli, and E. Marinello Behaviour of human lymphocytic isoenzymes of 5′-nucleotidase Life Sci 62 1998 2257 2266
192. F. Rosi, A. Tabucchi, F. Carlucci, P. Galieni, F. Lauria, and L. Zanoni 5′-nucleotidase activity in lymphocytes from patients affected by B-cell chronic lymphocytic leukemia Clin Biochem 31 1998 269 272
193. F. Rosi, F. Carlucci, E. Marinello, and A. Tabucchi Ecto-5′- nucleotidase in B-cell chronic lymphocytic leukemia Biomed Pharmacother 56 2002 100 104
194. A. Saada, A. Shaag, H. Mandel, Y. Nevo, S. Eriksson, and O. Elpeleg Mutant mitochondrial thymidine kinase in mitochondrial DNA depletion myopathy Nat Genet 29 2001 342 344
195. A. Saada, E. Ben-Shalom, R. Zyslin, C. Miller, H. Mandel, and O. Elpeleg Mitochondrial deoxyribonucleoside triphosphate pools in thymidine kinase 2 deficiency Biochem Biophys Res Commun 310 2003 963 966
196. A. Saada, A. Shaag, and O. Elpeleg mtDNA depletion myopathy: elucidation of the tissue specificity in the mitochondrial thymidine kinase (TK2) deficiency Mol Genet Metab 79 2003 1 5
197. G.B. Sala-Newby, and A.C. Newby Cloning of a mouse cytosolic 5′-nucleotidase-I identifies a new gene related to human autoimmune infertility-related protein Biochim Biophys Acta 1521 2001 12 18
198. G.B. Sala-Newby, A.C. Skladanowski, and A.C. Newby The mechanism of adenosine formation in cells. Cloning of cytosolic 5′-nucleotidase-I J Biol Chem 274 1999 17789 17793
199. G.B. Sala-Newby, N.V. Freeman, A.C. Skladanowski, and A.C. Newby Distinct roles for recombinant cytosolic 5′-nucleotidase-I and-II in AMP and IMP catabolism in COS-7 and H9c2 rat myoblast cell lines J Biol Chem 275 2000 11666 11671
200. G.B. Sala-Newby, N.V. Freeman, M.A. Curto, and A.C. Newby Metabolic and functional consequences of cytosolic 5′-nucleotidase-IA overexpression in neonatal rat cardiomyocytes Am J Physiol Heart Circ Physiol 285 2003 H991 H998
201. P.P. Saunders, C.D. Spindler, M.T. Tan, E. Alvarez, and R.K. Robins Tiazofurin is phosphorylated by three enzymes from Chinese hamster ovary cells Cancer Res 50 1990 5269 5274
202. D.A. Savaiano, and A.J. Clifford Adenine, the precursor of nucleic acids in intestinal cells unable to synthesize purines de novo J Nutr 111 1981 1816 1822
203. V. Savic, V. Stefanovic, N. Ardaillou, and R. Ardaillou Induction of ecto-5′-nucleotidase of rat cultured mesangial cells by interleukin-1beta and tumor necrosis factor-alfa Immunology 70 1990 321 326
204. M. Schirmer, A.P. Stegmann, F. Geisen, and G. Konwalinka Lack of cross-resistance with gemcitabine and cytarabine in cladribine-resistant HL60 cells with elevated 5′-nucleotidase activity Exp Hematol 26 1998 1223 1228
205. B. Schneider, R. Biondi, R. Sarfati, F. Agou, C. Guerreiro, and D. Deville-Bonne The mechanism of phosphorylation of anti-HIV D4T by nucleoside diphosphate kinase Mol Pharmacol 57 2000 948 953
206. G. Siegfried, F. Vrtovsnik, D. Prie, C. Amiel, and G. Friedlander Parathyroid hormone stimulates ecto-5′-nucleotidase activity in renal epithelial cells: role of protein kinase-C Endocrinology 136 1995 1267 1275
207. M. Sikorska, L.M. Brewer, T. Youdale, R. Richards, J.F. Whitfield, and R.A. Houghten Evidence that mammalian ribonucleotide reductase is a nuclear membrane associated glycoprotein Biochem Cell Biol 68 1990 880 888
208. A.C. Skladanowski, and A.C. Newby Partial purification and properties of an AMP-specific soluble 5′-nucleotidase from pigeon heart Biochem J 268 1990 117 122
209. A.C. Skladanowski, C.S. Hoffmann, J.D. Krass, W. Makarewicz, and B. Jastorff Different substrate specificity of two isozymes of cytosolic 5′-nucleotidase from rabbit heart Adv Exp Med Biol 370 1995 617 621
210. A.C. Skladanowski, R.T. Smolenski, M. Tavenier, J.W. de Jong, M.H. Yacoub, and A.M. Seymour Soluble forms of 5′-nucleotidase in rat and human heart Am J Physiol 270 1996 H1493 H1500
211. A.C. Skladanowski, A.C. Newby, and W. Makarewicz Purification and some molecular properties of pigeon heart AMP-selective 5′-nucleotidase Adv Exp Med Biol 431 1998 113 117
212. R.D. Snyder The role of deoxynucleoside triphosphate pools in the inhibition of DNA-excision repair and replication in human cells by hydroxyurea Mutat Res 131 1984 163 172
213. J. Spychala, and G. Van den Berghe Adenine nucleotide metabolism in isolated chicken hepatocytes Biochem J 242 1987 551 558
214. J. Spychala, and J. Kitajewski Wnt and beta-catenin signaling target the expression of ecto-5′-nucleotidase and increase extracellular adenosine generation Exp Cell Res 296 2004 99 108
215. m soluble 5′-nucleotidase from human placenta. Properties and allosteric regulation by IMP and ATP J Biol Chem 263 1988 18759 18765
216. m 5′-nucleotidases Am J Physiol 256 1989 E386 E391
217. J. Spychala, N.S. Datta, K. Takabayashi, M. Datta, I.H. Fox, and T. Gribbin Cloning of human adenosine kinase cDNA: sequence similarity to microbial ribokinases and fructokinases Proc Natl Acad Sci U S A 93 1996 1232 1237
218. J. Spychala, B.S. Mitchell, and J. Barankiewicz Adenosine metabolism during phorbol myristate acetate-mediated induction of HL-60 cell differentiation: changes in expression pattern of adenosine kinase, adenosine deaminase, and 5′-nucleotidase J Immunol 158 1997 4947 4952
219. m 5′-nucleotidase. Role of C-terminal polyglutamic acid tract in subunit association and catalytic activity Eur J Biochem 259 1999 851 858
220. J. Spychala, A.G. Zimmermann, and B.S. Mitchell Tissue-specific regulation of the ecto-5′-nucleotidase promoter: role of a CRE site in mediating repression by the upstream regulatory region J Biol Chem 274 1999 22705 22712
221. J. Spychala, E. Lazarowski, A. Ostapkowicz, L.H. Ayscue, A. Jin, and B.S. Mitchell Role of estrogen receptor in the regulation of ecto-5′- nucleotidase (eN) expression and extracellular adenosine generation in breast cancer Clin Cancer Res 10 2004 708 717
222. G.A. Spyrou, and P. Reichard Intracellular compartmentation of deoxycytidine nucleotide pools in S phase mouse 3T3 fibroblasts J Biol Chem 264 1989 960 964
223. U. Stochaj, J. Dieckhoff, J. Mollenhauer, M. Cramer, and H.G. Mannherz Evidence for the direct interaction of chicken gizzard 5′-nucleotidase with laminin and fibronectin Biochim Biophys Acta 992 1989 385 392
224. U. Stochaj, H. Richter, and H.G. Mannherz Chicken gizzard 5′-nucleotidase is a receptor for the extracellular matrix component fibronectin Eur J Cell Biol 51 1990 335 338
225. R.M. Stone, E. Sariban, G.R. Pettit, and D.W. Kufe Bryostatin 1 activates protein kinase C and induces monocytic differentiation of HL-60 cells Blood 72 1988 208 213
226. D.M. Swallow, V.S. Turner, and D.A. Hopkinson Isozymes of rodent 5′-nucleotidase: evidence for two independent structural loci Umph-1 and Umph-2 Ann Hum Genet 47 Pt 1 1983 9 17
227. K. Synnestvedt, G.T. Furuta, K.M. Comerford, N. Louis, J. Karhausen, and H.K. Eltzschig Ecto-5′-nucleotidase (CD73) regulation by hypoxia-inducible factor-1 mediates permeability changes in intestinal epithelia J Clin Invest 110 2002 993 1002
228. M. Tanaka, and S. Yoshida Altered sensitivity to 1-beta-d- arabinofuranosylcytosine 5′-triphosphate of DNA polymerase alpha from leukemic blasts of acute lymphoblastic leukemia Cancer Res 42 1982 649 653
229. M.H. Tattersall, K. Ganeshaguru, and A.V. Hoffbrand The effect of external deoxyribonucleosides on deoxyribonucleoside triphosphate concentrations in human lymphocytes Biochem Pharmacol 24 1975 1495 1498
230. L. Thelander, and P. Reichard Reduction of ribonucleotides Annu Rev Biochem 48 1979 133 158
231. L.F. Thompson, and J.M. Ruedi Synthesis of immunoglobin G by pokeweed mitogen or Epstein-Barr virus-stimulated human B cells in vitro is restricted to the ecto-5′-nucleotidase positive subset J Clin Invest 82 1988 902 905
232. L.F. Thompson, J.M. Ruedi, A. Glass, M.G. Low, and A.H. Lucas Antibodies to 5′-nucleotidase (Cd73), a glycosyl-phosphatidylinositol-anchored protein, cause human peripheral blood T-cells to proliferate J Immunol 143 1989 1815 1821
233. L.F. Thomson, J.M. Ruedi, A. Glass, G. Moldenhauer, P. Moller, and M.G. Low Production and characterization of monoclonal antibodies to the glycosyl phosphatidylinositol-anchored lymphocyte differentiation antigen ecto-5′-nucleotidase (CD73) Tissue Antigens 35 1990 9 19
234. L.F. Thompson, C.J. Van de Wiele, A.B. Laurent, S.W. Hooker, J.G. Vaughn, and H. Jiang Metabolites from apoptotic thymocytes inhibit thymopoiesis in adenosine deaminase-deficient fetal thymic organ cultures J Clin Invest 106 2000 1149 1157
235. M.G. Tozzi, M. Camici, R. Pesi, S. Allegrini, F. Sgarrella, and P.L. Ipata Nucleoside phosphotransferase activity of human colon carcinoma cytosolic 5′-nucleotidase Arch Biochem Biophys 291 1991 212 217
236. M. Trifilo, and T. Page NAPDD patients exhibit altered electrophoretic mobility of cytosolic 5′ nucleotidase Adv Exp Med Biol 486 2000 87 90
237. V.L. Truong, A.R. Collinson, and J.M. Lowenstein 5′-Nucleotidase in rat heart. Evidence for the occurrence of two soluble enzymes with different substrate specificities Biochem J 253 1988 117 121
238. P. Ujhazy, M. Klobusicka, O. Babusikova, P. Strausbauch, E. Mihich, and M.J. Ehrke Ecto-5′-nucleotidase (CD73) in multidrug-resistant cell lines generated by doxorubicin Int J Cancer 59 1994 83 93
239. P. Ujhazy, E.S. Berleth, J.M. Pietkiewicz, H. Kitano, J.R. Skaar, and M.J. Ehrke Evidence for the involvement of ecto-5′-nucleotidase (CD73) in drug resistance Int J Cancer 68 1996 493 500
240. W.N. Valentine, K. Fink, D.E. Paglia, S.R. Harris, and W.S. Adams Hereditary hemolytic anemia with human erythrocyte pyrimidine 5′-nucleotidase deficiency J Clin Invest 54 1974 866 879
241. C.J. Van De Wiele, J.G. Vaughn, M.R. Blackburn, C.A. Ledent, M. Jacobson, and H. Jiang Adenosine kinase inhibition promotes survival of fetal adenosine deaminase-deficient thymocytes by blocking dATP accumulation J Clin Invest 110 2002 395 402
242. R.A. Van den Bosch, A.P.M. du Maine, H.J. Geuze, A. van der Ende, and G.J. Strous Recycling of 5′-nucleotidase in rat hepatoma cell line EMBO J 7 1988 3345 3351
243. A.R. Van Rompay, M. Johansson, and A. Karlsson Phosphorylation of nucleosides and nucleoside analogs by mammalian nucleoside monophosphate kinases Pharmacol Ther 87 2000 189 198
244. A.R. Van Rompay, A. Norda, K. Linden, M. Johansson, and A. Karlsson Phosphorylation of uridine and cytidine nucleoside analogs by two human uridine-cytidine kinases Mol Pharmacol 59 2001 1181 1186
245. M. Wakamiya, M.R. Blackburn, R. Jurecic, M.J. McArthur, R.S. Geske, and J. Cartwright Jr. Disruption of the adenosine deaminase gene causes hepatocellular impairment and perinatal lethality in mice Proc Natl Acad Sci U S A 92 1995 3673 3677
246. W. Wang, R. Kim, J. Jancarik, H. Yokota, and S.H. Kim Crystal structure of phosphoserine phosphatase from Methanococcus jannaschii, a hyperthermophile, at 1.8 A resolution Structure 9 2001 65 71
247. Y. Worku, and A.C. Newby Nucleoside exchange catalysed by the cytoplasmic 5′-nucleotidase Biochem J 205 1982 503 510
248. Y.-Z. Xu, P. Huang, and W. Plunkett Functional compartmentation of dCTP pools. Preferential utilization of salvaged deoxycytidine for DNA repair in human lymphoblasts J Biol Chem 270 1995 631 637
249. Y. Yamazaki, V.L. Truong, and J.M. Lowenstein 5′-Nucleotidase-I from rabbit heart Biochemistry 30 1991 1503 1509
250. G.G. Yegutkin, T. Henttinen, and S. Jalkanen Extracellular ATP formation on vascular endothelial cells is mediated by ecto-nucleotide kinase activities via phosphotransfer reactions FASEB J 15 2001 251 260
251. G.G. Yegutkin, T. Henttinen, S.S. Samburski, J. Spychala, and S. Jalkanen The evidence of two opposite, ATP-generating and ATP-consuming, extracellular pathways on endothelial and lymphoid cells Biochem J 367 2002 121 128
252. H. Zimmermann 5′-Nucleotidase: molecular structure and functional aspects Biochem J 285 1992 345 365